Medicare Reimbursement For Investigative Devices Supported By IoM

Medicare should automatically cover the cost of investigative category B medical devices for beneficiaries participating in randomized clinical studies, an Institute of Medicine committee recommends in a report, "Extending Medicare Reimbursement in Clinical Trials," released Dec. 15 at a press briefing in Washington, D.C.